Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Prenetics Group ( (PRE) ) has issued an update.
Prenetics Global Limited announced changes to its Board of Directors, with the term of Ms. Kathryn Henry ending on June 12, 2025, and the appointment of Kong Yiu (Andy) Cheung as an independent director and Audit Committee member effective June 16, 2025. Mr. Cheung, with his extensive experience in digital asset operations and financial technology, is expected to enhance Prenetics’ strategic capabilities, particularly in Bitcoin treasury strategies and digital asset initiatives, as the company explores innovative applications in healthcare.
The most recent analyst rating on (PRE) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Prenetics Group stock, see the PRE Stock Forecast page.
Spark’s Take on PRE Stock
According to Spark, TipRanks’ AI Analyst, PRE is a Neutral.
Prenetics Group’s overall score is driven primarily by its financial performance, which highlights significant profitability and cash flow challenges. The technical analysis provides some positive signals, but valuation concerns due to negative earnings weigh heavily on the stock’s attractiveness. The lack of earnings call data and notable corporate events means these factors do not influence the score.
To see Spark’s full report on PRE stock, click here.
More about Prenetics Group
Average Trading Volume: 24,862
Technical Sentiment Signal: Buy
Current Market Cap: $91.37M
See more insights into PRE stock on TipRanks’ Stock Analysis page.